The diagnostic utility of the lognormal behavior of PET standardized uptake values in tumors

J. A. Thie, Karl Hubner, G. T. Smith

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

A meta-analysis of data primarily from PET oncologic investigations using FDG PET was performed. Its purpose was to establish statistical features of the distributions of standardized uptake values (SUVs) as possible aids in the diagnostic process. Methods: We obtained 1536 values of oncologic markers from patient studies of 40 investigations in the literature. Statistical parameters were tabulated for analysis. Results: A significant observation is that, unlike skewed SUV histograms, log10SUV has Gaussian behavior, which is not uncommon for biologic quantities. This was found for SUVs of FDG and 2 amino acids as well as a few other cancer markers. A possible model for explaining this is proposed. For FDG, the SD σ of the log10SUVs for an average cancer category was 0.23. Examining data within the framework of the model points to physiologic factors as dominating SUV variability rather than PET protocols. When data for a single cancer category were available from multiple institutions, averages, S̄ŪV̄s, disagree beyond chance expectations. Diagnostic utility suggestions include a universal linear relationship between sensitivity and severity, defined as SUV/S̄ŪV̄, on semilogarithmic probability paper; a generic receiver-operating-characteristic curve for all cancers; using [log10(S̄ŪV̄(mal)/S̄ŪV̄(norm))] / (σ(mal)2 + σ(norm)2)(1/2) as a simple diagnostic effectiveness measure; and using Gaussian log10SUVs to avoid erroneous P values. Conclusion: Using the logarithms of markers, such as SUVs, several advantages stemming from their Gaussian nature can be achieved with benefits ensuing to the diagnostic process.

Original languageEnglish (US)
Pages (from-to)1664-1672
Number of pages9
JournalJournal of Nuclear Medicine
Volume41
Issue number10
StatePublished - Jan 1 2000

Fingerprint

Neoplasms
Statistical Distributions
ROC Curve
Meta-Analysis
Observation
Amino Acids
PET protocol

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

The diagnostic utility of the lognormal behavior of PET standardized uptake values in tumors. / Thie, J. A.; Hubner, Karl; Smith, G. T.

In: Journal of Nuclear Medicine, Vol. 41, No. 10, 01.01.2000, p. 1664-1672.

Research output: Contribution to journalArticle

@article{8647c1ade17b4d18b3edb8d964e2fcd1,
title = "The diagnostic utility of the lognormal behavior of PET standardized uptake values in tumors",
abstract = "A meta-analysis of data primarily from PET oncologic investigations using FDG PET was performed. Its purpose was to establish statistical features of the distributions of standardized uptake values (SUVs) as possible aids in the diagnostic process. Methods: We obtained 1536 values of oncologic markers from patient studies of 40 investigations in the literature. Statistical parameters were tabulated for analysis. Results: A significant observation is that, unlike skewed SUV histograms, log10SUV has Gaussian behavior, which is not uncommon for biologic quantities. This was found for SUVs of FDG and 2 amino acids as well as a few other cancer markers. A possible model for explaining this is proposed. For FDG, the SD σ of the log10SUVs for an average cancer category was 0.23. Examining data within the framework of the model points to physiologic factors as dominating SUV variability rather than PET protocols. When data for a single cancer category were available from multiple institutions, averages, S̄ŪV̄s, disagree beyond chance expectations. Diagnostic utility suggestions include a universal linear relationship between sensitivity and severity, defined as SUV/S̄ŪV̄, on semilogarithmic probability paper; a generic receiver-operating-characteristic curve for all cancers; using [log10(S̄ŪV̄(mal)/S̄ŪV̄(norm))] / (σ(mal)2 + σ(norm)2)(1/2) as a simple diagnostic effectiveness measure; and using Gaussian log10SUVs to avoid erroneous P values. Conclusion: Using the logarithms of markers, such as SUVs, several advantages stemming from their Gaussian nature can be achieved with benefits ensuing to the diagnostic process.",
author = "Thie, {J. A.} and Karl Hubner and Smith, {G. T.}",
year = "2000",
month = "1",
day = "1",
language = "English (US)",
volume = "41",
pages = "1664--1672",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "10",

}

TY - JOUR

T1 - The diagnostic utility of the lognormal behavior of PET standardized uptake values in tumors

AU - Thie, J. A.

AU - Hubner, Karl

AU - Smith, G. T.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - A meta-analysis of data primarily from PET oncologic investigations using FDG PET was performed. Its purpose was to establish statistical features of the distributions of standardized uptake values (SUVs) as possible aids in the diagnostic process. Methods: We obtained 1536 values of oncologic markers from patient studies of 40 investigations in the literature. Statistical parameters were tabulated for analysis. Results: A significant observation is that, unlike skewed SUV histograms, log10SUV has Gaussian behavior, which is not uncommon for biologic quantities. This was found for SUVs of FDG and 2 amino acids as well as a few other cancer markers. A possible model for explaining this is proposed. For FDG, the SD σ of the log10SUVs for an average cancer category was 0.23. Examining data within the framework of the model points to physiologic factors as dominating SUV variability rather than PET protocols. When data for a single cancer category were available from multiple institutions, averages, S̄ŪV̄s, disagree beyond chance expectations. Diagnostic utility suggestions include a universal linear relationship between sensitivity and severity, defined as SUV/S̄ŪV̄, on semilogarithmic probability paper; a generic receiver-operating-characteristic curve for all cancers; using [log10(S̄ŪV̄(mal)/S̄ŪV̄(norm))] / (σ(mal)2 + σ(norm)2)(1/2) as a simple diagnostic effectiveness measure; and using Gaussian log10SUVs to avoid erroneous P values. Conclusion: Using the logarithms of markers, such as SUVs, several advantages stemming from their Gaussian nature can be achieved with benefits ensuing to the diagnostic process.

AB - A meta-analysis of data primarily from PET oncologic investigations using FDG PET was performed. Its purpose was to establish statistical features of the distributions of standardized uptake values (SUVs) as possible aids in the diagnostic process. Methods: We obtained 1536 values of oncologic markers from patient studies of 40 investigations in the literature. Statistical parameters were tabulated for analysis. Results: A significant observation is that, unlike skewed SUV histograms, log10SUV has Gaussian behavior, which is not uncommon for biologic quantities. This was found for SUVs of FDG and 2 amino acids as well as a few other cancer markers. A possible model for explaining this is proposed. For FDG, the SD σ of the log10SUVs for an average cancer category was 0.23. Examining data within the framework of the model points to physiologic factors as dominating SUV variability rather than PET protocols. When data for a single cancer category were available from multiple institutions, averages, S̄ŪV̄s, disagree beyond chance expectations. Diagnostic utility suggestions include a universal linear relationship between sensitivity and severity, defined as SUV/S̄ŪV̄, on semilogarithmic probability paper; a generic receiver-operating-characteristic curve for all cancers; using [log10(S̄ŪV̄(mal)/S̄ŪV̄(norm))] / (σ(mal)2 + σ(norm)2)(1/2) as a simple diagnostic effectiveness measure; and using Gaussian log10SUVs to avoid erroneous P values. Conclusion: Using the logarithms of markers, such as SUVs, several advantages stemming from their Gaussian nature can be achieved with benefits ensuing to the diagnostic process.

UR - http://www.scopus.com/inward/record.url?scp=0033781697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033781697&partnerID=8YFLogxK

M3 - Article

VL - 41

SP - 1664

EP - 1672

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 10

ER -